K. Abbaci Daghor

Methotrexate in Still’s Disease: An Updated Perspective on Efficacy and Safety

The EULAR/PreS and American College of Rheumatology (ACR) guidelines for Still's disease (SD) were recently published with new therapeutic management strategies to achieve therapeutic targets within a specified timeframe. The early use of interleukin (IL)-1 or IL-6 inhibitors ass...